SMS Lifesciences India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 87.63 | 82.94 | 79.75 |
| Operating Expense | 79.83 | 69.81 | 66.70 |
| Net Profit | 2.68 | 6.23 | 6.01 |
| Net Profit Margin | 3.06 | 7.51 | 7.54 |
| Earning Per Share | 8.85 | 20.60 | 19.87 |
| EBIDTA | 8.14 | 13.06 | 13 |
| Effective Tax Rate | 12.82 | 17.59 | 19.14 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 87.63 |
| Operating Expense | 79.83 |
| Net Profit | 2.68 |
| Net Profit Margin | 3.06 |
| Earning Per Share | 8.85 |
| EBIDTA | 8.14 |
| Effective Tax Rate | 12.82 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 300.00 | 315.24 | 345.63 |
| Operating Expenses Annual | 265.57 | 288.84 | 314.26 |
| Operating Profit Annual | 38.27 | 31.64 | 45.59 |
| Interest Annual | 8.90 | 5.09 | 4.63 |
| Depreciation | 9.56 | 7.53 | 7.51 |
| Net Profit Annual | 13.07 | 13.22 | 25.38 |
| Tax Annual | 6.05 | 5.15 | 7.60 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 300.00 |
| Operating Expenses Annual | 265.57 |
| Operating Profit Annual | 38.27 |
| Interest Annual | 8.90 |
| Depreciation | 9.56 |
| Net Profit Annual | 13.07 |
| Tax Annual | 6.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.15 | 0.95 | 8.46 |
| Cash Flow from Operations | 14.75 | 4.58 | -14.66 |
| Cash Flow from Investing | -13.75 | -27.96 | -7.49 |
| Cash Flow from Financing | -0.82 | 22.59 | 14.63 |
| Cash Flow at the End | 0.33 | 0.15 | 0.95 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.15 |
| Cash Flow from Operations | 14.75 |
| Cash Flow from Investing | -13.75 |
| Cash Flow from Financing | -0.82 |
| Cash Flow at the End | 0.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.67 | 8.25 | 8.67 |
| PBIT Margin (%) | 8.56 | 5.93 | 6.56 |
| PBT Margin (%) | 7.61 | 4.78 | 5.16 |
| Net PROFIT Margin (%) | 3.98 | 3.76 | 6.69 |
| Return On Networth / Equity (%) | 7.68 | 7.20 | 11.47 |
| Return On Networth /Employed (%) | 10.68 | 8.85 | 12.54 |
| Return On Assets (%) | 4.97 | 5.60 | 12.79 |
| Total Debt / Equity (X) | 0.53 | 0.47 | 0.39 |
| Asset Turnover Ratio (%) | 1.25 | 1.49 | 1.91 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.67 |
| PBIT Margin (%) | 8.56 |
| PBT Margin (%) | 7.61 |
| Net PROFIT Margin (%) | 3.98 |
| Return On Networth / Equity (%) | 7.68 |
| Return On Networth /Employed (%) | 10.68 |
| Return On Assets (%) | 4.97 |
| Total Debt / Equity (X) | 0.53 |
| Asset Turnover Ratio (%) | 1.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 138.23 | 139.61 | 98.72 |
| Total Current Assets Annual | 174.49 | 167.59 | 162.32 |
| Non Current Assets Annual | 172.88 | 169.80 | 149.68 |
| Total Shareholders Funds Annual | 176.23 | 164.03 | 151.21 |
| Total Assets Annual | 347.38 | 337.39 | 312.00 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 138.23 |
| Total Current Assets Annual | 174.49 |
| Non Current Assets Annual | 172.88 |
| Total Shareholders Funds Annual | 176.23 |
| Total Assets Annual | 347.38 |
EPS (INR)
Expected
9.83
Reported
9.83
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by -0.17%
Jun 2024
EPS beaten by 0.00%
